Seems you never bothered reading my post, just the sentiment.
I base it on the fact that the POC diagnostic market is 75% made up of glycose and infectious disease tests.
That the cardiac marker POC market is predominantly in the USA, a market that Philips minicare will not have access to until FDA approval which conservatively speaking wont happen before 2018.
If they get CE marked for use in Europe, they will have to compete for what is at most, a 100 million market share.that market share is dominated with heavy hitters already established.
We know royalties from ADO aren't big because of previous deals.
3% in the opinion of 1 expert far more qualified than posters here would be massive.
3% of the whole European market is only maybe 3 million.
Time to get real guys.
Look at previous deals.All were over estimated in revenue earning
History repeats itself because it's not listened to the first time.
Seems you never bothered reading my post, just the sentiment. I...
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
-0.001(4.55%) |
Mkt cap ! $50.57M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.3¢ | 2.1¢ | $38.09K | 1.731M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 1505316 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.3¢ | 676543 | 1 |
View Market Depth
| Last trade - 15.57pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
2.2¢ |
Change
-0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 2.2¢ | 2.3¢ | 2.2¢ | 764931 | ||
| Last updated 15.55pm 03/05/2024 ? | |||||
| ADO (ASX) Chart |